A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma H Geminder, O Sagi-Assif, L Goldberg, T Meshel, G Rechavi, IP Witz, ... The Journal of Immunology 167 (8), 4747-4757, 2001 | 529 | 2001 |
A history of exploring cancer in context S Maman, IP Witz Nature Reviews Cancer 18 (6), 359-376, 2018 | 461 | 2018 |
CXCL10 promotes invasion-related properties in human colorectal carcinoma cells A Zipin-Roitman, T Meshel, O Sagi-Assif, B Shalmon, C Avivi, RM Pfeffer, ... Cancer research 67 (7), 3396-3405, 2007 | 235 | 2007 |
The tumor microenvironment: the making of a paradigm IP Witz Cancer Microenvironment 2, 9-17, 2009 | 205 | 2009 |
The tumor microenvironment in the post-PAGET era IP Witz, O Levy-Nissenbaum Cancer letters 242 (1), 1-10, 2006 | 188 | 2006 |
The selectin–selectin ligand axis in tumor progression IP Witz Cancer and Metastasis Reviews 27, 19-30, 2008 | 181 | 2008 |
Tumor–microenvironment interactions: Dangerous liaisons IP Witz Advances in cancer research 100, 203-229, 2008 | 171 | 2008 |
Yin-yang activities and vicious cycles in the tumor microenvironment IP Witz Cancer research 68 (1), 9-13, 2008 | 129 | 2008 |
Tumor-Bound Immunoglobulins: in SituExpressions Of Humoral Immunity IP Witz Advances in Cancer Research 25, 95-148, 1977 | 127 | 1977 |
Cancer drug resistance induced by EMT: novel therapeutic strategies J De Las Rivas, A Brozovic, S Izraely, A Casas-Pais, IP Witz, A Figueroa Archives of toxicology 95 (7), 2279-2297, 2021 | 118 | 2021 |
The expression of the chemokine receptor CXCR3 and its ligand, CXCL10, in human breast adenocarcinoma cell lines L Goldberg-Bittman, E Neumark, O Sagi-Assif, E Azenshtein, T Meshel, ... Immunology letters 92 (1-2), 171-178, 2004 | 117 | 2004 |
PROTECTIVE AND CELLULAR IMMUNE RESPONSES TO IDIOTYPIC DETERMINANTS ON CELLS FROM A SPONTANEOUS LYMPHOMA OF NZB/NZW F1 MICE S Sugai, DW Palmer, N Talal, IP Witz The Journal of Experimental Medicine 140 (6), 1547-1558, 1974 | 115 | 1974 |
Astrocytes facilitate melanoma brain metastasis via secretion of IL‐23 A Klein, H Schwartz, O Sagi‐Assif, T Meshel, S Izraely, S Ben Menachem, ... The Journal of pathology 236 (1), 116-127, 2015 | 113 | 2015 |
Tumor‐associated immunoglobulins. Enhancement of syngeneic tumors by IgG2‐containing tumor eluates M Ran, IP Witz International journal of cancer 9 (1), 242-247, 1972 | 111 | 1972 |
The CASC15 long intergenic noncoding RNA locus is involved in melanoma progression and phenotype switching L Lessard, M Liu, DM Marzese, H Wang, K Chong, N Kawas, ... Journal of Investigative Dermatology 135 (10), 2464-2474, 2015 | 108 | 2015 |
Epigenetic changes of EGFR have an important role in BRAF inhibitor–resistant cutaneous melanomas J Wang, SK Huang, DM Marzese, SC Hsu, NP Kawas, KK Chong, ... Journal of Investigative Dermatology 135 (2), 532-541, 2015 | 104 | 2015 |
The focal adhesion kinase (P125FAK) is constitutively active in human malignant melanoma O Kahana, M Micksche, IP Witz, I Yron Oncogene 21 (25), 3969-3977, 2002 | 99 | 2002 |
The relationship between in vitro fertilization and naturally occurring antibodies: evidence for increased production of antiphospholipid autoantibodies B Fisch, Y Rikover, L Shohat, N Zurgil, Y Tadir, J Ovadia, IP Witz, I Yron Fertility and sterility 56 (4), 718-724, 1991 | 90 | 1991 |
The biological significance of tumor-bound immunoglobulins IP Witz Current Topics in Microbiology and Immunology/Ergebnisse der Mikrobiologie …, 1973 | 90 | 1973 |
The metastatic microenvironment: brain‐residing melanoma metastasis and dormant micrometastasis S Izraely, O Sagi‐Assif, A Klein, T Meshel, G Tsarfaty, M Pasmanik‐Chor, ... International journal of cancer 131 (5), 1071-1082, 2012 | 89 | 2012 |